These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8666147)

  • 1. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR).
    Ferrannini E; Vichi S; Beck-Nielsen H; Laakso M; Paolisso G; Smith U
    Diabetes; 1996 Jul; 45(7):947-53. PubMed ID: 8666147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).
    Vaag A; Lehtovirta M; Thye-Rönn P; Groop L;
    Diabet Med; 2001 Jul; 18(7):533-40. PubMed ID: 11553181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions.
    Sumner AE; Kushner H; Sherif KD; Tulenko TN; Falkner B; Marsh JB
    Diabetes Care; 1999 Jan; 22(1):71-7. PubMed ID: 10333906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of postabsorptive endogenous glucose output in non-diabetic subjects. European Group for the Study of Insulin Resistance (EGIR).
    Natali A; Toschi E; Camastra S; Gastaldelli A; Groop L; Ferrannini E
    Diabetologia; 2000 Oct; 43(10):1266-72. PubMed ID: 11079745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty.
    Arslanian SA; Kalhan SC
    Diabetes; 1994 Jul; 43(7):908-14. PubMed ID: 8013756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR).
    Ferrannini E; Natali A; Capaldo B; Lehtovirta M; Jacob S; Yki-Järvinen H
    Hypertension; 1997 Nov; 30(5):1144-9. PubMed ID: 9369268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers.
    Abbasi F; McLaughlin T; Lamendola C; Reaven GM
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1251-4. PubMed ID: 10720071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production.
    Steinberg HO; Paradisi G; Hook G; Crowder K; Cronin J; Baron AD
    Diabetes; 2000 Jul; 49(7):1231-8. PubMed ID: 10909983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Oakes ND; Thalén PG; Jacinto SM; Ljung B
    Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension.
    Agata J; Miyazaki Y; Takada M; Murakami H; Masuda A; Miura T; Ura N; Shimamoto K
    Hypertens Res; 1998 Mar; 21(1):57-62. PubMed ID: 9582109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
    Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
    Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT
    Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans.
    Carpentier A; Patterson BW; Leung N; Lewis GF
    Diabetes; 2002 Jun; 51(6):1867-75. PubMed ID: 12031975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
    Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
    Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of free fatty acids on glucose uptake and utilization in healthy women.
    Homko CJ; Cheung P; Boden G
    Diabetes; 2003 Feb; 52(2):487-91. PubMed ID: 12540625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM.
    Paolisso G; Tataranni PA; Foley JE; Bogardus C; Howard BV; Ravussin E
    Diabetologia; 1995 Oct; 38(10):1213-7. PubMed ID: 8690174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.